Vincent Ippolito
Fortune : 287 862 $ au 31/05/2026
Fortune : 287 862 $ au 31/05/2026
Mr. Vincent P.
Ippolito is an Executive Chairman & President at Botanix Pharmaceuticals Ltd. and an Executive Chairman & President at Botanix Pharmaceuticals, Inc. He is on the Board of Directors at Suneva Medical, Inc. Mr. Ippolito was previously employed as a President & Chief Operating Officer by Dermavant Sciences, Inc., a Chief Commercial Officer & Executive VP by Anacor Pharmaceuticals LLC, a Senior Vice President & General Manager-Aesthetics by Bausch Health Cos., Inc., a Chief Commercial Officer, EVP-Sales & Marketing by Medicis Pharmaceutical Corp., and a Vice President-Sales by Novartis AG.
He received his undergraduate degree from the University of Wisconsin-Eau Claire.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 16 668 311 ( 0,61 % ) | 287 862 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BOTANIX PHARMACEUTICALS LIMITED | Président | 18/07/2019 |
Suneva Medical, Inc.
Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and commercializes novel, differentiated aesthetic products | Directeur/Membre du Conseil | 28/08/2017 |
Botanix Pharmaceuticals, Inc.
Botanix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of musculoskeletal diseases, such as oacne, psoriasis and atopic dermatitis | Président | 01/07/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | President | 01/01/2019 |
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | 30/09/2017 |
| MEDICIS PHARMACEUTICAL CORP | Sales & Marketing | 01/03/2014 |
| NOVARTIS AG | Sales & Marketing | 02/01/2003 |
| BAUSCH HEALTH COMPANIES INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Medicis Pharmaceutical Corp.
Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for dermatological usages | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Botanix Pharmaceuticals Ltd.
Botanix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dermatology and antimicrobial products | Health Technology |
Anacor Pharmaceuticals LLC
Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Bausch Health Cos., Inc.
Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Suneva Medical, Inc.
Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and commercializes novel, differentiated aesthetic products | Electronic Technology |
University of Wisconsin-Eau Claire
University of Wisconsin-Eau Claire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Botanix Pharmaceuticals, Inc.
Botanix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of musculoskeletal diseases, such as oacne, psoriasis and atopic dermatitis | Health Technology |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national